Airing weekdays at 7:30 A.M. on

Airing weekdays at 7:30 A.M. on

EmCyte Corporation® is the world leader in autologous Platelet Rich Plasma and Progenitor Stem Cell Biologics. Its product portfolio meets the highest achievable performance standard at the point of care.

It has an innovation that remains on the cutting edge of excellence and improves clinical outcomes for patients around the world. More power, versatility, efficiency, and quality at the point of care.

Miami-based plastic and reconstructive surgeon Dr. George M. Varkarakis explains that the human body contains powerful healing properties that are unlike anything in the world. The body has an array of proteins and cell mediators that can identify and repair damaged tissue in the body. These tissue types are found in the blood, bone marrow, and adipose cells. EmCyte’s President/CEO Patrick Pennie talks about their patented technology, which effectively concentrates these tissue types into a powerful treatment sample that can be applied to an injury or wound.

Health, Wealth, Beauty, and Business

Bringing the best tips from the experts in Atlanta in business, beauty, wealth management, child healthcare, car shopping, and more. Each year, Atlanta’s Women’s Entrepreneurship Initiative selects 15 local female entrepreneurs for a 15-month business training program. We meet women who have grown their companies, created jobs, and broke through the glass ceiling. With some […]

iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.

There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.

Comments

comments